Newsletter due out soon, will they leave it until after the...

First 4 Last

Share
Profile

Follow
Splatta

388 Posts.

1

21/01/16

12:40

Post #: 16841066
Share

Originally posted by Smugtown ↑

Patience from here IMO - the path is already laid out.
(understand the frustration tho!)

We have a qtrly in 10 or so days which will be pivotal in showing us how much traction they have made in the US with their sales force agreement.

However the big ticket item for me is these snippets from the chairmans address to shareholders on Nov 24:
"We are also conducting a post-approval clinical trial, the primary goal of which is to provide data for health economics studies of PeriCoach. This trial will give us independent evidence to give to the health departments and private health insurers around the world so that the use of the PeriCoach is funded by these agencies"
"With the PeriCoach, Analytica can offer all seven points to a potential multinational partner - they want a product that has been tested in the market place, that is ready to go and has been de-risked and we have done this. Our strategy is to approach any potential partner once we have the results of the clinical trial. The independent data and the health economics outcomes are important, but the trial’s secondary endpoint examining Female Sexual Dysfunction is equally exciting"

So the reality is it will be months before we prove up the clinical trial and see any partner agreement - which is going to be the big driver of share price here.

I invite all to read through the announcement on Nov 24 when getting impatient, to help quell the frustration!

Expand

Newsletter due out soon, will they leave it until after the Oppies expire?
Advised that timing has not been set for this yet.

Cheers

ALT Price at posting: 0.5¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

First 4 Last

Add ALT (ASX) to my watchlist

Newsletter due out soon, will they leave it until after the...

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Featured News